Design Therapeutics DSGN SEC Filings

NASDAQ DSGN
$10.65 -0.15 (-1.39%)
At close: Nov 10, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Design Therapeutics, Inc. (DSGN) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001193125-26-447258Nov 4, 2026 9:11 PM
28-KCurrent Report0001193125-26-447235Nov 4, 2026 9:08 PM
3S-3Prospectus0001193125-26-447545Nov 4, 2026 4:58 PM
4424B5Prospectus0001193125-26-447373Nov 4, 2026 4:27 PM
5SCHEDULE 13GBeneficial Ownership Report0000919574-26-005487Aug 14, 2026 8:07 PM
6SCHEDULE 13GBeneficial Ownership Report0000919574-26-005202Aug 14, 2026 12:32 PM
710-QQuarterly & Annual Report0001193125-26-329579Aug 3, 2026 12:07 PM
88-KCurrent Report0001193125-26-329570Aug 3, 2026 12:03 PM
94Insider Transaction0001193125-26-267732Jun 11, 2026 8:41 PM
104Insider Transaction0001478916-26-000009Jun 11, 2026 8:15 PM
114Insider Transaction0001579826-26-000002Jun 11, 2026 8:15 PM
124Insider Transaction0001754129-26-000006Jun 11, 2026 8:15 PM
134Insider Transaction0001559570-26-000008Jun 11, 2026 8:15 PM
144Insider Transaction0001751873-26-000002Jun 11, 2026 8:15 PM
158-KCurrent Report0001193125-26-267485Jun 11, 2026 8:05 PM
16SCHEDULE 13GBeneficial Ownership Report0000919574-26-003921Jun 9, 2026 9:02 PM
178-KCurrent Report0001193125-26-227875May 18, 2026 11:15 AM
18SCHEDULE 13GBeneficial Ownership Report0000919574-26-003492May 15, 2026 8:26 PM
1910-QQuarterly & Annual Report0001193125-26-187063Apr 28, 2026 8:13 PM
208-KCurrent Report0001193125-26-187012Apr 28, 2026 8:09 PM
21DEFA14AOthers0001193125-26-173689Apr 23, 2026 8:08 PM
22DEF 14AOthers0001193125-26-173678Apr 23, 2026 8:06 PM
23ARSOthers0001193125-26-173640Apr 23, 2026 8:02 PM
244Insider Transaction0001559570-26-000006Apr 1, 2026 8:17 PM
253Insider Transaction0001559570-26-000004Apr 1, 2026 8:11 PM
268-KCurrent Report0001193125-26-137861Apr 1, 2026 8:03 PM
27SCHEDULE 13DBeneficial Ownership Report0001072613-26-000257Mar 11, 2026 1:28 AM
28S-8Prospectus0001193125-26-098540Mar 9, 2026 8:16 PM
2910-KQuarterly & Annual Report0001193125-26-098491Mar 9, 2026 8:08 PM
308-KCurrent Report0001193125-26-098474Mar 9, 2026 8:06 PM
31SCHEDULE 13GBeneficial Ownership Report0000902664-26-001131Feb 17, 2026 9:27 PM
328-KCurrent Report0001193125-26-031772Jan 30, 2026 9:05 PM
334Insider Transaction0001674703-26-000002Jan 5, 2026 9:14 PM
344Insider Transaction0001848377-26-000002Jan 5, 2026 9:13 PM
354Insider Transaction0001883722-26-000002Jan 5, 2026 9:11 PM
364Insider Transaction0001754129-26-000002Jan 5, 2026 9:10 PM
374Insider Transaction0001580787-26-000002Jan 5, 2026 9:08 PM
384Insider Transaction0001580787-25-000006Dec 11, 2025 9:30 PM
39SCHEDULE 13DBeneficial Ownership Report0000935836-25-000710Nov 18, 2025 10:57 PM
40144Insider Transaction0001178937-25-000065Nov 18, 2025 9:28 PM
41144Insider Transaction0001178937-25-000060Nov 14, 2025 9:18 PM
42SCHEDULE 13DBeneficial Ownership Report0000935836-25-000657Nov 12, 2025 10:10 PM
43144Insider Transaction0001178937-25-000059Nov 7, 2025 10:24 PM
4410-QQuarterly & Annual Report0001193125-25-266970Nov 5, 2025 9:15 PM
458-KCurrent Report0001193125-25-266933Nov 5, 2025 9:10 PM
464Insider Transaction0001415889-25-024109Sep 10, 2025 9:18 PM
473Insider Transaction0001415889-25-024108Sep 10, 2025 9:17 PM
488-KCurrent Report0001807120-25-000004Sep 10, 2025 8:04 PM
49SCHEDULE 13GBeneficial Ownership Report0000902664-25-003881Aug 28, 2025 8:05 PM
504Insider Transaction0001415889-25-021842Aug 14, 2025 8:15 PM
...

Design Therapeutics, Inc. SEC Filings API

Pull Design Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=DSGN&formtype=10-K,10-Q&api_key=YOUR_API_KEY